Skip to main content

Table 2 Percentage of children under five with fever in the 2 weeks before the survey who received treatment with anti-malarial drug by country

From: Prompt access to effective malaria treatment among children under five in sub-Saharan Africa: a multi-country analysis of national household survey data

Country

Children with fever in the 2 weeks before the survey

Children who received ACT among those who received any anti-malarial treatment

Received any anti-malarial

Received ACT

% (95% CI)

N

Year

% (95% CI)

% (95% CI)

N

Angola

28.3 (26.6–30.0)

21.7 (20.1–23.2)

2645

76.6 (73.5–79.6)

738

2011

Benina

54.0 (52.5–55.5)

0.9 (0.6–1.1)

4204

1.6 (1.1–2.1)

2243

2006

Ethiopia

3.6 (2.8–4.4)

1.3 (0.8–1.8)

2082

36.3 (27.8–44.9)

124

2011

Ghana

43.0 (38.8–47.1)

21.5 (18.1–24.9)

551

50.0 (44.5–56.6)

225

2008

Kenya

23.2 (20.9–25.4)

7.8 (6.3–9.2)

1385

33.5 (28.2–38.7)

311

2009

Liberia

57.1 (54.7–59.5)

39.7 (37.3–42.1)

1617

69.6 (66.5–72.6)

895

2011

Madagascar

19.8 (17.3–22.4)

3.8 (2.6–5.0)

959

19.3 (13.4–25.1)

177

2011

Malawi

32.5 (29.0–36.0)

29.6 (26.1–33.0)

676

91.0 (87.1–94.8)

216

2012

Mali

34.7 (31.2–38.2)

7.8 (5.8–9.7)

705

22.4 (17.1–27.6)

243

2010

Mozambique

29.9 (27.4–32.4)

17.9 (15.8–20.0)

1313

59.9 (54.9–64.9)

366

2011

Rwanda

10.8 (9.2–12.5)

10.4 (8.7–12.0)

1332

95.7 (92.3–99.1)

140

2010

Senegal

8.2 (7.1–9.3)

3.4 (2.6–4.1)

2314

41.0 (33.7–48.3)

176

2010

Tanzania mainland

60.1 (57.4–62.7)

37.9 (35.1–40.6)

1320

63.1 (59.7–66.5)

785

2010

Uganda

64.5 (62.7–66.2)

44.2 (42.4–46.1)

2860

68.6 (66.5–70.7)

1849

2010

Zambia

38.4 (35.4–41.3)

11.1 (9.2–13.0)

1034

29.0 (24.6–33.4)

417

2007

Zanzibar

16.9 (12.5–21.3)

5.6 (2.9–8.3)

282

33.1 (18.3–48.0)

42

2010

  1. 95 % CI 95 % confidence interval, N number of children
  2. aArtemisinin combination therapy [ACT] was rolled out in Benin only 2 years before the survey